Dr James Michael Cockrell, MD | |
6144 Airport Blvd, Mobile, AL 36608-3143 | |
(251) 476-5050 | |
(251) 450-2770 |
Full Name | Dr James Michael Cockrell |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 38 Years |
Location | 6144 Airport Blvd, Mobile, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306803838 | NPI | - | NPPES |
200028694 | Other | RAILROAD MEDICARE | |
00110440 | Medicaid | MS | |
631187140 | Other | TAX ID | |
051035088 | Other | AL | BCBS |
000035091 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207XX0005X | Orthopaedic Surgery - Sports Medicine | 00013616 (Alabama) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Orthopaedic Group Pc | 2264331826 | 67 |
News Archive
Inherited genetic makeup often plays a role in determining the risk level for certain diseases, including alcoholism.
Public affairs experts say easy and constant access by citizens to important government information, referred to as government transparency, is vital for good governance as well as the perception by citizens that the government is trustworthy.
Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
Affymetrix, Inc. today announced that the U.S. District Court for the Western District of Wisconsin (the "Court") has granted the company's motion for summary judgment that Affymetrix does not infringe the patents held by Illumina, Inc., and has directed that the patent infringement lawsuits brought against the company by Illumina regarding U.S. Patent Nos. 7,510,841 and 7,612,020 be dismissed and the cases closed.
Today, the U.S. Food and Drug Administration issued a new report titled, "Resiliency Roadmap for FDA Inspectional Oversight," outlining the agency's inspectional activities during the COVID-19 pandemic and its detailed plan to move toward a more consistent state of operations, including the FDA's priorities related to this work going forward.
› Verified 8 days ago
Entity Name | The Orthopaedic Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164489951 PECOS PAC ID: 2264331826 Enrollment ID: O20040102000844 |
News Archive
Inherited genetic makeup often plays a role in determining the risk level for certain diseases, including alcoholism.
Public affairs experts say easy and constant access by citizens to important government information, referred to as government transparency, is vital for good governance as well as the perception by citizens that the government is trustworthy.
Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
Affymetrix, Inc. today announced that the U.S. District Court for the Western District of Wisconsin (the "Court") has granted the company's motion for summary judgment that Affymetrix does not infringe the patents held by Illumina, Inc., and has directed that the patent infringement lawsuits brought against the company by Illumina regarding U.S. Patent Nos. 7,510,841 and 7,612,020 be dismissed and the cases closed.
Today, the U.S. Food and Drug Administration issued a new report titled, "Resiliency Roadmap for FDA Inspectional Oversight," outlining the agency's inspectional activities during the COVID-19 pandemic and its detailed plan to move toward a more consistent state of operations, including the FDA's priorities related to this work going forward.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr James Michael Cockrell, MD Po Box 86144, Mobile, AL 36689-6144 Ph: (251) 476-5050 | Dr James Michael Cockrell, MD 6144 Airport Blvd, Mobile, AL 36608-3143 Ph: (251) 476-5050 |
News Archive
Inherited genetic makeup often plays a role in determining the risk level for certain diseases, including alcoholism.
Public affairs experts say easy and constant access by citizens to important government information, referred to as government transparency, is vital for good governance as well as the perception by citizens that the government is trustworthy.
Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
Affymetrix, Inc. today announced that the U.S. District Court for the Western District of Wisconsin (the "Court") has granted the company's motion for summary judgment that Affymetrix does not infringe the patents held by Illumina, Inc., and has directed that the patent infringement lawsuits brought against the company by Illumina regarding U.S. Patent Nos. 7,510,841 and 7,612,020 be dismissed and the cases closed.
Today, the U.S. Food and Drug Administration issued a new report titled, "Resiliency Roadmap for FDA Inspectional Oversight," outlining the agency's inspectional activities during the COVID-19 pandemic and its detailed plan to move toward a more consistent state of operations, including the FDA's priorities related to this work going forward.
› Verified 8 days ago
Derek Klavas, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6144 Airport Blvd, Mobile, AL 36608 Phone: 251-476-5050 | |
Dr. Matthew L Webb, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1601 Center St, Mobile, AL 36604 Phone: 251-665-8200 Fax: 251-665-8210 | |
Dr. Charles Henry Wilson Iv, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6144 Airport Blvd, Mobile, AL 36608 Phone: 251-476-5050 Fax: 251-450-2770 | |
Dr. Robert Ball Mcginley, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6144 Airport Blvd, Mobile, AL 36608 Phone: 251-476-5050 Fax: 251-450-2770 | |
Dr. Blake David Bowden, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1720 Spring Hill Ave Ste 3, Mobile, AL 36604 Phone: 251-435-2663 Fax: 251-435-1098 | |
Dr. Todd David Engerson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6144 Airport Blvd, Mobile, AL 36608 Phone: 251-476-5050 Fax: 251-450-2770 | |
Dr. Grantham Mcaleer Shell, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1720 Spring Hill Ave Fl 3, Mobile, AL 36604 Phone: 251-435-2663 |